Gilead Announces New Sustained Viral Response Data for Sofosbuvir-Based Regimens in Genotype 

Gilead Announces New Sustained Viral Response Data for Sofosbuvir-Based Regimens in Genotype 3-Infected Hepatitis C Patients
Business Wire
 
View Comments